OPKO Health Research and Development Expenses 2010-2023 | OPK
OPKO Health Annual Research and Development Expenses (Millions of US $) |
|
---|---|
2023 | $90 |
2022 | $74 |
2021 | $77 |
2020 | $75 |
2019 | $118 |
2018 | $126 |
2017 | $126 |
2016 | $114 |
2015 | $99 |
2014 | $84 |
2013 | $54 |
2012 | $20 |
2011 | $11 |
2010 | $6 |
2009 | $11 |
OPKO Health Quarterly Research and Development Expenses (Millions of US $) |
|
---|---|
2023-12-31 | $19 |
2023-09-30 | $19 |
2023-06-30 | $18 |
2023-03-31 | $33 |
2022-12-31 | $20 |
2022-09-30 | $19 |
2022-06-30 | $17 |
2022-03-31 | $18 |
2021-12-31 | $21 |
2021-09-30 | $18 |
2021-06-30 | $18 |
2021-03-31 | $19 |
2020-12-31 | $17 |
2020-09-30 | $18 |
2020-06-30 | $18 |
2020-03-31 | $22 |
2019-12-31 | $23 |
2019-09-30 | $30 |
2019-06-30 | $28 |
2019-03-31 | $37 |
2018-12-31 | $33 |
2018-09-30 | $30 |
2018-06-30 | $29 |
2018-03-31 | $33 |
2017-12-31 | $34 |
2017-09-30 | $33 |
2017-06-30 | $33 |
2017-03-31 | $27 |
2016-12-31 | $-70 |
2016-09-30 | $24 |
2016-06-30 | $31 |
2016-03-31 | $128 |
2015-12-31 | $25 |
2015-09-30 | $19 |
2015-06-30 | $30 |
2015-03-31 | $26 |
2014-12-31 | $26 |
2014-09-30 | $21 |
2014-06-30 | $16 |
2014-03-31 | $21 |
2013-12-31 | $23 |
2013-09-30 | $11 |
2013-06-30 | $10 |
2013-03-31 | $10 |
2012-12-31 | $7 |
2012-09-30 | $4 |
2012-06-30 | $4 |
2012-03-31 | $5 |
2011-12-31 | $4 |
2011-09-30 | $3 |
2011-06-30 | $3 |
2011-03-31 | $1 |
2010-12-31 | $2 |
2010-09-30 | $2 |
2010-06-30 | $2 |
2010-03-31 | $1 |
2009-12-31 | $-0 |
2009-09-30 | $3 |
2009-06-30 | $2 |
2009-03-31 | $6 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.878B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $225.480B | 27.32 |
Intuitive Surgical (ISRG) | United States | $135.098B | 81.39 |
Edwards Lifesciences (EW) | United States | $51.040B | 33.22 |
DexCom (DXCM) | United States | $49.691B | 75.27 |
IQVIA Holdings (IQV) | United States | $41.731B | 24.21 |
IDEXX Laboratories (IDXX) | United States | $41.543B | 48.69 |
Alcon (ALC) | Switzerland | $39.902B | 28.59 |
STERIS (STE) | Ireland | $22.980B | 26.85 |
Waters (WAT) | United States | $20.719B | 30.45 |
Hologic (HOLX) | United States | $17.636B | 19.73 |
SONOVA HOLDING (SONVY) | Switzerland | $17.555B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $12.711B | 14.84 |
ShockWave Medical (SWAV) | United States | $12.404B | 77.19 |
Sysmex ADR (SSMXY) | Japan | $10.586B | 33.20 |
Teleflex (TFX) | United States | $9.765B | 15.20 |
Globus Medical (GMED) | United States | $8.630B | 25.30 |
Penumbra (PEN) | United States | $7.938B | 90.21 |
Masimo (MASI) | United States | $6.166B | 35.52 |
Glaukos (GKOS) | United States | $5.458B | 0.00 |
TransMedics (TMDX) | United States | $4.349B | 412.62 |
Integer Holdings (ITGR) | United States | $3.776B | 22.81 |
LivaNova (LIVN) | United Kingdom | $3.311B | 19.66 |
PROCEPT BioRobotics (PRCT) | United States | $3.265B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.865B | 19.66 |
Tandem Diabetes Care (TNDM) | United States | $2.837B | 0.00 |
Inari Medical (NARI) | United States | $2.650B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.582B | 21.84 |
RxSight (RXST) | United States | $2.175B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $2.065B | 9.01 |
Veracyte (VCYT) | United States | $1.720B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.558B | 0.00 |
Artivion (AORT) | United States | $0.967B | 92.80 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.913B | 17.75 |
Silk Road Medical (SILK) | United States | $0.817B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.742B | 0.00 |
Paragon 28 (FNA) | United States | $0.673B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.628B | 21.31 |
SiBone (SIBN) | United States | $0.618B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.564B | 0.00 |
IRadimed (IRMD) | United States | $0.538B | 30.11 |
Pacific Biosciences Of California (PACB) | United States | $0.526B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.395B | 0.00 |
Nevro (NVRO) | United States | $0.374B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.329B | 11.24 |
Treace Medical Concepts (TMCI) | United States | $0.281B | 0.00 |
Sight Sciences (SGHT) | United States | $0.270B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
AxoGen (AXGN) | United States | $0.253B | 0.00 |
AngioDynamics (ANGO) | United States | $0.245B | 0.00 |
NeuroPace (NPCE) | United States | $0.245B | 0.00 |
908 Devices (MASS) | United States | $0.226B | 0.00 |
Inogen (INGN) | United States | $0.208B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.183B | 0.00 |
CVRx (CVRX) | United States | $0.166B | 0.00 |
Semler Scientific (SMLR) | United States | $0.163B | 8.27 |
ClearPoint Neuro (CLPT) | United States | $0.160B | 0.00 |
Accuray (ARAY) | United States | $0.157B | 0.00 |
Delcath Systems (DCTH) | United States | $0.150B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.103B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.096B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.089B | 18.62 |
Neuronetics (STIM) | United States | $0.077B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.063B | 0.00 |
Envoy Medical (COCH) | United States | $0.061B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.060B | 0.00 |
Hyperfine (HYPR) | United States | $0.057B | 0.00 |
InspireMD (NSPR) | Israel | $0.056B | 0.00 |
DarioHealth (DRIO) | United States | $0.052B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.050B | 0.00 |
Vasomedical (VASO) | United States | $0.050B | 9.00 |
Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
LENSAR (LNSR) | United States | $0.044B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.042B | 0.00 |
Precision Optics (POCI) | United States | $0.037B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.036B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
Spectral AI (MDAI) | United States | $0.029B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.027B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.024B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
PAVmed (PAVM) | United States | $0.018B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
NexGel (NXGL) | United States | $0.014B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Tenon Medical (TNON) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |